VanHimbergen Robert M 4

What Happened

• Robert M. VanHimbergen, EVP and Chief Financial Officer of Elanco Animal Health (ELAN), was granted 9.485 deferred stock units on 2026-03-06. The units were valued at $23.36 each for a total grant value of about $222. This was an award/grant (transaction code A) — a form of compensation, not an open-market purchase.

Key Details

• Transaction date: 2026-03-06; Form 4 filed: 2026-03-10 (Accession: 0001724169-26-000012).
• Grant details: 9.485 deferred stock units at $23.36 per unit; aggregate value ≈ $222.
• Shares owned after the transaction: not specified in the filing.
• Instrument type: derivative (deferred stock units, not direct share issuance).
• Footnotes: Each deferred stock unit represents the right to one share or the cash equivalent; DSUs settle in cash or shares following termination or in a specified future year under the Executive Deferral and Stock Match Plan.
• Filing timeliness: filing date is shown; the report does not state any late-filing code here.

Context

• Deferred stock units are a compensation/deferral vehicle — they do not represent immediate share ownership and typically convert to shares or cash at a later date or upon termination. Such grants are routine executive compensation and should be interpreted as pay-related rather than a direct bullish purchase signal.